Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
LSL Pharma Group Inc
V.LSL
Alternate Symbol(s):
LPGIF
Consumer Defensive
Household & Personal Products
LSL Pharma Group Inc. is a Canadian integrated pharmaceutical company. The Company is specializing in the development, manufacturing and distribution of natural health products and dietary supplements in solid dosage forms, as well as sterile ophthalmic pharmaceutical products. The Company’s subsidiaries include Steri-Med Pharma Inc., LSL Laboratory Inc. and Groupe Immobilier LSL inc.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:LSL)
New Post
View:
Posts & Comments
Threaded Posts
(0)
•••
goochcroggins
X
View Profile
View Bullboard History
Post by
goochcroggins
on Mar 07, 2024 9:08am
More dilutive financings and warrants. I'm out!
BOUCHERVILLE, Qubec, March 07, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL) (the "Corporation" or "LSL Pharma "), a Canadian integrated pharmaceutical
...more
(0)
•••
LuxueuxIV
X
View Profile
View Bullboard History
Post by
LuxueuxIV
on Jan 25, 2024 6:07pm
New web site LSL Pharma group
See corporate presentation https://www.groupelslpharma.com/en Seems that a lot of potential coming in the following months . FDA etc
Fresh Insight into the Topaz Helium Project's Expected Size and Scale
posted Apr 26, 2024 9:00am by
Pulsar Helium Inc.
-
|
The prospective zone is very broad. We believe its not just an isolated occurrence but is actually something quite regionally extensive ...read more
(1925)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Jun 20, 2023 7:33pm
Groupe LSL Pharma Update on Increased Production Capacity
BOUCHERVILLE, Quebec, June 20, 2023 (GLOBE NEWSWIRE) -- GROUPE LSL PHARMA INC (TSXV: LSL) - Groupe LSL Pharma Inc. ("the Company" or " LSL Pharma Group "), a Canadian integrated
...more
(2)
•••
Brudom2002
X
View Profile
View Bullboard History
Comment by
Brudom2002
on Mar 01, 2023 11:02am
RE:web site 2 divisions LSL Pharma
Je crois galement qu'il y a un bon potentiel mais ce matin, il y en a un qui tait dans le financement et qui voudrait absolument qu'il y ait des ventes 1,00$. Pas srieux
(0)
•••
Luxieuxone
X
View Profile
View Bullboard History
Post by
Luxieuxone
on Mar 01, 2023 10:53am
web site 2 divisions LSL Pharma
https://www.laboratoirelsl.com/?lang=en & https://sterimedpharma.com/en/home/
(0)
•••
Luxieuxone
X
View Profile
View Bullboard History
Post by
Luxieuxone
on Mar 01, 2023 9:59am
Today a new beginning, trading for the first time
LSL Pharma going from private to public , very good potential
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Two New Contracts Awarded Covering Five Onshore Fields Producing 3,000 bbl/d of Oil
Fresh Insight into the Topaz HELIUM Project's Expected Size and Scale
Exploration company provides project portfolio update
Centurion Identifies High Quality Gold Target-Casa Berardi West Project; Acquires Additional Claims
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study